These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11080813)

  • 1. HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex.
    Sagara Y; Inoue Y; Kojima E; Shiraki H; Maeda Y
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1701-4. PubMed ID: 11080813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells.
    Sagara Y; Inoue Y; Kojima E; Ishida C; Shiraki H; Maeda Y
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):125-35. PubMed ID: 11177392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
    Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
    J Virol; 1998 Jan; 72(1):535-41. PubMed ID: 9420256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
    Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
    Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.
    Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
    J Virol; 1997 Jan; 71(1):601-7. PubMed ID: 8985389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
    Brighty DW; Jassal SR
    J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
    Jassal SR; Lairmore MD; Leigh-Brown AJ; Brighty DW
    Virus Res; 2001 Oct; 78(1-2):17-34. PubMed ID: 11520577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
    Piñon JD; Klasse PJ; Jassal SR; Welson S; Weber J; Brighty DW; Sattentau QJ
    J Virol; 2003 Sep; 77(18):9922-30. PubMed ID: 12941902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
    J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
    Sagara Y; Inoue Y; Shiraki H; Jinno A; Hoshino H; Maeda Y
    J Virol; 1996 Mar; 70(3):1564-9. PubMed ID: 8627675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.
    Jinno A; Haraguchi Y; Shiraki H; Hoshino H
    J Virol; 1999 Nov; 73(11):9683-9. PubMed ID: 10516085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.
    Sagara Y; Inoue Y; Tsujimura M; Kojima E; Shiraki H; Kashiwagi S
    Cancer Sci; 2004 Oct; 95(10):835-9. PubMed ID: 15504252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
    Hadlock KG; Yang Q; Rowe J; Foung SK
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):57-70. PubMed ID: 11804557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
    Jassal SR; Pöhler RG; Brighty DW
    J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
    Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
    Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.